Prescription drug · NDA
25% Dextrose Infant NDC 51662-1213
Dextrose monohydrate 250 mg/mL · Injection, Solution · Intravenous · HF Acquisition Co. LLC, DBA Health First
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1213-1 | 51662121301 | 1 SYRINGE, PLASTIC in 1 CARTON (51662-1213-1) / 10 mL in 1 SYRINGE, PLASTICMarketed from Aug 19, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- 25% Dextrose Infant
- Generic name (nonproprietary)
- 25% dextrose infant
- Active ingredients
- Dextrose monohydrate — 250 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019445
- Marketing start
- Listing expires
- Identifiers
- Product ID 51662-1213_ef6a78fb-553f-a83e-e053-2995a90a6164SPL ID ef6a78fb-553f-a83e-e053-2995a90a6164SPL set ID 73d04839-a2bb-65dd-e053-2991aa0a82caRxCUI 727518UNII LX22YL083G
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662121301followed by a unit qualifier and the quantityPackage 51662-1213-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE 25% Dextrose Injection is indicated in the treatment of acute symptomatic episodes of hypoglycemia in the neonate or older infant to restore depressed blood glucose levels and control symptoms. Other drugs, such as epinephrine and glucagon, should be considered in patients unresponsive or intolerant to dextrose (glucose). Oral feeding of dextrose may be necessary in infants with frequently recurring hypoglycemic episodes or to prevent recurrences due to hyperinsulinemia. 25% Dextrose Injection also provides a minimal source of carbohydrate calories.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019445
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dextrosedextrose monohydrate | Dextrose monohydrate 250 mg/mL | Injection, SolutionIntravenous | REMEDYREPACK INC. | 70518-4452 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | REMEDYREPACK INC. | 70518-4219 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 250 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1775 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-7517 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 250 mg/mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | 71872-7214 |
| Dextrose | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1215 |
| 50% Dextrose | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1216 |
| Infant Dextrosedextrose | Dextrose monohydrate 250 mg/mL | Injection, SolutionIntravenous | Henry Schein, Inc. | 0404-9844 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Henry Schein, Inc. | 0404-9845 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Henry Schein, Inc. | 0404-9847 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | 71872-7003 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | ProPharma Distribution | 84549-517 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | 71872-7057 |
| Dextrosedextrose monohydrate | Dextrose monohydrate 25 g/50mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-6648 |